Latest papers

Mirtazapine-induced akathisia.

Greater incidence of emergence agitation in children after sevoflurane anesthesia as compared with halothane: a meta-analysis of randomized controlled trials.

Aripiprazole improves neuroleptic-associated tardive dyskinesia, but it does not meliorate psychotic symptoms.

Successful treatment of delusional disorder with low-dose aripiprazole.

Activation syndrome caused by paroxetine in a cancer patient.

Aripiprazole treatment causes extrapyramidal side effects but not prolactin elevation: a disconnect of the striatal D2 occupancy story: case report.

Oral manifestations of adverse drug reactions: guidelines.

Role of mirtazapine in the treatment of antipsychotic-induced akathisia.

Antipsychotic-induced movement disorders - forgotten but not gone.

Akathisia in adults with severe and profound intellectual disability: a psychometric study of the MEDS and ARMS.

Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia.

Do partial agonists cause akathisia: the role of the mental health nurse who prescribes.

Propofol for the management of glycine-mediated excitatory symptoms of TURP syndrome.

Benign tongue FDG uptake in a patient with tardive dyskinesia.

Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.

Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.

Aripiprazole's receptor pharmacology and extrapyramidal side effects.

Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment.

Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.